Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 2
Author(s): Ferdinando Nicoletti
Affiliation:
Export Options
About this article
Cite this article as:
Nicoletti Ferdinando , Meet Our Editorial Board Member, Current Neuropharmacology 2018; 16 (2) . https://dx.doi.org/10.2174/1570159X1602180130155228
DOI https://dx.doi.org/10.2174/1570159X1602180130155228 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
28
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Proteolytic Cleavage of Notch: “HIT and RUN”
Current Molecular Medicine The Possibility of Novel Antiplatelet Peptides: The Physiological Effects of Low Molecular Weight HSPs on Platelets
Current Pharmaceutical Design Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery
Current Pharmaceutical Design Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Reproduction in Couples with Chronic Viral Infections
Current Women`s Health Reviews Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
Current Diabetes Reviews QSAR Multi-Target in Drug Discovery: A Review
Current Computer-Aided Drug Design Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse- Deterrent Formulations
Current Pharmaceutical Design Molecular Imaging in the Default Mode Network
Current Molecular Imaging (Discontinued) Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Up-Regulation of TLR-4 in the Brain After Ischemic Kidney-Induced Encephalopathy in the Rat
CNS & Neurological Disorders - Drug Targets The CNS Melanocortin System: A Biological Weapon Against the Threat of Obesity
Current Medicinal Chemistry - Central Nervous System Agents The Role of the New Zealand Intensive Medicines Monitoring Programme in Identification of Previously Unrecognised Signals of Adverse Drug Reactions
Current Drug Safety Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China
Current Alzheimer Research Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders
Current Drug Metabolism Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design Author Index to Volume 1
Current Neurovascular Research Neuronal Semaphorins Regulate a Primary Immune Response
Current Neurovascular Research Heterocyclic Analogues as Kinase Inhibitors: A Focus Review
Current Topics in Medicinal Chemistry